Eprosartan Mesylate; Hydrochlorothiazide Patent Expiration
Eprosartan Mesylate; Hydrochlorothiazide is Used for managing high blood pressure. It was first introduced by Abbvie Inc
Eprosartan Mesylate; Hydrochlorothiazide Patents
Given below is the list of patents protecting Eprosartan Mesylate; Hydrochlorothiazide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Teveten Hct | US5656650 | Angiotensin II receptor blocking compositions |
Aug 12, 2014
(Expired) | Abbvie |
Eprosartan Mesylate; Hydrochlorothiazide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List